AIP-208

AIP-208 is a preclinical radiopharmaceutical diagnostic candidate being developed by AIP Medical (Advanced Innovative Partners) for the imaging and detection of Glioblastoma Multiforme (GBM). As part of AIP Medical's oncology pipeline, this agent is designed to utilize radioactive isotopes to provide precise visualization of glioblastoma tumors, potentially assisting in the diagnosis, staging, and surgical planning for patients with this aggressive brain malignancy. The specific molecular target and radioisotope used in AIP-208 have not been publicly disclosed, but the candidate is positioned as a novel tool in the diagnostic workup of high-grade gliomas.